Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
GSK Shingrix Shingles Vaccine Seen Displacing Zostavax After US FDA Approval
Oct 23 2017
•
By
Sten Stovall
GSK's Shingrix is a big improvement on the existing shingles vaccine, Zostavax • Source: Shutterstock
More from New Products
More from Scrip